George Budwell
George Budwell, PhD, is a contributing Motley Fool biotechnology and technology analyst covering disruptive innovators in healthcare, defense, and artificial intelligence. He also writes on portfolio theory, dividend stocks, and value investing. Prior to The Motley Fool, George was a freelance medical and science writer and a consultant for several life sciences hedge funds. Earlier in his career, he was an evolutionary biologist and completed postdoctoral fellowships at Kyoto University and Illinois State University. He holds a doctorate in evolutionary biology from Tulane University and a bachelor’s degree from Loyola University.
Recent Articles by George Budwell

2 Incredible Growth Stocks I'm Buying Hand Over Fist

2 High-Quality Dividend Stocks to Buy Right Now

3 Essential AI Infrastructure Stocks to Buy Right Now

2 AI Stocks I Can't Stop Buying

3 Dividend Growth Stocks to Buy Right Now

Is D-Wave Quantum Stock Still a Buy?

2 Space Stocks I'm Buying on the Dip

5 Top AI Stocks I'm Buying on the Dip

Is Joby Aviation Stock a Buy?

25 Top AI Stocks That Could Boost Your Portfolio

3 Tech Defense Stocks That Could Be the Next Palantir

2 Cutting-Edge AI Stocks I'm Buying on the Dip
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.